Dengue virus serum type 3 epidemic strain GZ14D3 replicon and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUN YAT SEN UNIV
- Publication Date
- 2021-11-05
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of genetic engineering, in particular to a dengue virus serotype 3 epidemic strain GZ14D3 replicon and application thereof. Background technique
[0002] A series of diseases caused by dengue virus (DENV) infection are important mosquito-borne viral diseases in tropical areas at present, and the vectors are Aedes aegypti and Aedes albopictus. Before 1970, 9 countries had serious dengue fever epidemics, and dengue has affected more than 100 countries in tropical and subtropical regions at present, and about 390 million dengue fever infection cases occur every year, and about 70% of the cases occur in Asia. The World Health Organization estimates a 30-fold increase in the observed global incidence over the past 50 years. Today, dengue virus poses a major threat to public health worldwide, with approximately two-fifths of the world's population at risk of dengue infection.
[0003] Globally, there are four serotypes of...